GLI1 and prostate carcinoma: Tzelepi et al. found that epithelial expression of GLI1, SHH, SMO, and PTCH by immunohistochemistry was higher in primary prostate carcinomas compared with non-neoplastic peripheral zone tissue, but was lower in the surrounding stromal tissue.